Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Cognitive Dysfunction × Drug Therapy × Clear all

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Tobacco Use Cessation 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Diseases 1 Pancreatic Cancer Liver Metastases 1 Ovarian Neoplasms 1 Ototoxicity 1 Neoplasms, Second Primary 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Hodgkin Disease 1 Hearing Loss 1 HER2 Positive Metastatic Breast Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1

Interventions

lithium sulfate 1 Radiotherapy 1 Population Groups 1 Lithium 1 Drug Therapy 1 Diet, Mediterranean 1 Diet, Fat-Restricted 1 Chemoradiotherapy 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡